Mototsugu Shimokawa

Treatment and survival among 1594 patients with ATL

Hiroo Katsuya, Kenji Ishitsuka, Atae Utsunomiya et al. · Blood · 2015 · 302 citations · Full text

Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma

Kazuki Takada, Tatsuro Okamoto, Fumihiro Shoji et al. · Journal of Thoracic Oncology · 2016 · 185 citations · Full text

Tumor Biology, Medicine, Immunology +8

Computed tomography features of resected lung adenocarcinomas with spread through air spaces

Gouji Toyokawa, Yuichi Yamada, Tetsuzo Tagawa et al. · Journal of Thoracic and Cardiovascular Surgery · 2018 · 107 citations · Full text

Computed Tomography, Resected Lung Adenocarcinomas, Medical Imaging +9

Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)

Hiroshi Saeki, Eiji Oki, Tomomi Kashiwada et al. · European Journal of Cancer · 2018 · 97 citations

Her2 Status, Surgical Oncology, Oncology +6

Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer

Hiroshige Yoshioka, Mototsugu Shimokawa, Takashi Seto et al. · Annals of Oncology · 2019 · 89 citations